{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:35:53Z","timestamp":1778531753454,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stiftelsen Thelma Zo\u00e9gas foundation for medical research"},{"name":"the Royal Physiographic Society of Lund"},{"name":"The Swedish Government Funds for Clinical Research (ALF)"},{"DOI":"10.13039\/501100005390","name":"Alfred \u00d6sterlunds Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lundgren Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10096-018-3367-7","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T01:27:38Z","timestamp":1536370058000},"page":"2261-2272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2778-5314","authenticated-orcid":false,"given":"Anna","family":"Bl\u00e4ckberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Nilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"\u00d6zenci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Olaison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"issue":"1","key":"3367_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10156-010-0084-2","volume":"17","author":"T Takahashi","year":"2011","unstructured":"Takahashi T, Ubukata K, Watanabe H (2011) Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features. J Infect Chemother 17(1):1\u201310. \n                    https:\/\/doi.org\/10.1007\/s10156-010-0084-2","journal-title":"J Infect Chemother"},{"issue":"4","key":"3367_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1128\/jcm.02188-07","volume":"46","author":"D Tanaka","year":"2008","unstructured":"Tanaka D, Isobe J, Watahiki M, Nagai Y, Katsukawa C, Kawahara R, Endoh M, Okuno R, Kumagai N, Matsumoto M, Morikawa Y, Ikebe T, Watanabe H (2008) Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield\u2019s group A antigen. J Clin Microbiol 46(4):1526\u20131529. \n                    https:\/\/doi.org\/10.1128\/jcm.02188-07","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3367_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/23744235.2015.1043940","volume":"47","author":"CS Jensen","year":"2015","unstructured":"Jensen CS, Dam-Nielsen C, Arpi M (2015) Matrix-assisted laser desorption\/ionization-time of flight mass spectrometry identification of large colony beta-hemolytic streptococci containing Lancefield groups A, C, and G. Infect Dis (Lond) 47(8):575\u2013579. \n                    https:\/\/doi.org\/10.3109\/23744235.2015.1043940","journal-title":"Infect Dis (Lond)"},{"issue":"5","key":"3367_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1086\/605085","volume":"49","author":"CM Brandt","year":"2009","unstructured":"Brandt CM, Spellerberg B (2009) Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 49(5):766\u2013772. \n                    https:\/\/doi.org\/10.1086\/605085","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3367_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1128\/jcm.05900-11","volume":"50","author":"A Jensen","year":"2012","unstructured":"Jensen A, Kilian M (2012) Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol 50(1):113\u2013126. \n                    https:\/\/doi.org\/10.1128\/jcm.05900-11","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3367_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.diagmicrobio.2016.09.008","volume":"86","author":"K Trell","year":"2016","unstructured":"Trell K, Nilson B, Rasmussen M (2016) Species and emm-type distribution of group C and G streptococci from different sites of isolation. Diagn Microbiol Infect Dis 86(4):467\u2013469. \n                    https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"3367_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3201\/eid1605.080803","volume":"16","author":"S Rantala","year":"2010","unstructured":"Rantala S, Vahakuopus S, Vuopio-Varkila J, Vuento R, Syrjanen J (2010) Streptococcus dysgalactiae subsp. equisimilis bacteremia, Finland, 1995-2004. Emerg Infect Dis 16(5):843\u2013846. \n                    https:\/\/doi.org\/10.3201\/eid1605.080803","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"3367_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10096-014-2092-0","volume":"33","author":"S Rantala","year":"2014","unstructured":"Rantala S (2014) Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis 33(8):1303\u20131310. \n                    https:\/\/doi.org\/10.1007\/s10096-014-2092-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3367_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2017.06.015","volume":"89","author":"O Oppegaard","year":"2017","unstructured":"Oppegaard O, Mylvaganam HSS, Jordal S, Glambek M, Kittang BR (2017) Clinical and molecular characteristics of infective \u03b2-hemolytic streptococcal endocarditis. Diagn Microbiol Infect Dis 89(2):135\u2013142","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3367_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2017.10.018","volume":"65","author":"SA Lother","year":"2017","unstructured":"Lother SA, Jassal DS, Lagace-Wiens P, Keynan Y (2017) Emerging group C and group G streptococcal endocarditis: a Canadian perspective. Int J Infect Dis 65:128\u2013132. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2017.10.018","journal-title":"Int J Infect Dis"},{"issue":"5","key":"3367_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/23744235.2015.1129672","volume":"48","author":"A Rafei El","year":"2016","unstructured":"El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, Wilson WR, Baddour LM (2016) Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis (Lond) 48(5):373\u2013378. \n                    https:\/\/doi.org\/10.3109\/23744235.2015.1129672","journal-title":"Infect Dis (Lond)"},{"issue":"21","key":"3367_CR12","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1001\/archinte.162.21.2450","volume":"162","author":"A Lefort","year":"2002","unstructured":"Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL (2002) Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med 162(21):2450\u20132456","journal-title":"Arch Intern Med"},{"issue":"2","key":"3367_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1128\/AAC.26.2.260","volume":"26","author":"K Lam","year":"1984","unstructured":"Lam K, Bayer AS (1984) In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci. Antimicrob Agents Chemother 26(2):260\u2013262","journal-title":"Antimicrob Agents Chemother"},{"key":"3367_CR14","unstructured":"Berge A, Ekdahl C, Ekspong L, Julander I, Kurland S, Olaison L, Rasmussen M, Snygg Martin U, Westling K (2016) Infective Endocarditis Working Group, Swedish Society of Infectious Diseases, Sweden May 2016. \n                    http:\/\/infektion.net\/wp-content\/uploads\/2017\/05\/vardprogram_infektios_endokardit.pdf\n                    \n                  . Accessed 20 Apr 2018"},{"issue":"1","key":"3367_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jinf.2011.11.003","volume":"64","author":"P Sendi","year":"2012","unstructured":"Sendi P, Ericsson M, Olaison L (2012) Infective endocarditis caused by group B Streptococcus: the role of aminoglycoside-combination. J Infect 64(1):127\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.jinf.2011.11.003","journal-title":"J Infect"},{"issue":"15","key":"3367_CR16","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/cir.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O\u2019Gara P, Taubert KA (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435\u20131486. \n                    https:\/\/doi.org\/10.1161\/cir.0000000000000296","journal-title":"Circulation"},{"issue":"1","key":"3367_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79(1):33\u201345. \n                    https:\/\/doi.org\/10.1038\/ki.2010.337","journal-title":"Kidney Int"},{"issue":"23","key":"3367_CR18","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/0006-2952(82)90303-3","volume":"31","author":"G Laurent","year":"1982","unstructured":"Laurent G, Carlier MB, Rollman B, Van Hoof F, Tulkens P (1982) Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 31(23):3861\u20133870","journal-title":"Biochem Pharmacol"},{"issue":"44","key":"3367_CR19","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL (2015) 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075\u20133128. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv319","journal-title":"Eur Heart J"},{"issue":"2","key":"3367_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0163-4453(88)94022-4","volume":"16","author":"EG Smyth","year":"1988","unstructured":"Smyth EG, Pallett AP, Davidson RN (1988) Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect 16(2):169\u2013176","journal-title":"J Infect"},{"issue":"5","key":"3367_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1128\/jcm.01794-09","volume":"48","author":"A Bizzini","year":"2010","unstructured":"Bizzini A, Durussel C, Bille J, Greub G, Prod\u2019hom G (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48(5):1549\u20131554. \n                    https:\/\/doi.org\/10.1128\/jcm.01794-09","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3367_CR22","doi-asserted-by":"publisher","first-page":"O255","DOI":"10.1111\/1469-0691.12373","volume":"20","author":"E Matuschek","year":"2014","unstructured":"Matuschek E, Brown DF, Kahlmeter G (2014) Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 20(4):O255\u2013O266. \n                    https:\/\/doi.org\/10.1111\/1469-0691.12373","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"3367_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1128\/AAC.22.5.930","volume":"22","author":"KV Rolston","year":"1982","unstructured":"Rolston KV, LeFrock JL, Schell RF (1982) Activity of nine antimicrobial agents against Lancefield group C and group G streptococci. Antimicrob Agents Chemother 22(5):930\u2013932","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3367_CR24","first-page":"391","volume":"5","author":"AS Bayer","year":"1983","unstructured":"Bayer AS, Lam K (1983) In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra. Clin Ther 5(4):391\u2013397","journal-title":"Clin Ther"},{"issue":"3","key":"3367_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.diagmicrobio.2013.07.006","volume":"77","author":"GA Pankey","year":"2013","unstructured":"Pankey GA, Ashcraft DS, Dornelles A (2013) Comparison of 3 Etest\u00ae methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species. Diagn Microbiol Infect Dis 77(3):220\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.07.006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"3367_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1128\/AAC.7.5.522","volume":"7","author":"AJ Weinstein","year":"1975","unstructured":"Weinstein AJ, Moellering RC Jr (1975) Studies of cephalothin: aminoglycoside synergism against enterococci. Antimicrob Agents Chemother 7(5):522\u2013529","journal-title":"Antimicrob Agents Chemother"},{"key":"3367_CR27","doi-asserted-by":"publisher","unstructured":"Sunnerhagen T, Hammarlund P, Rasmussen M (2015) A case of suspected infective endocarditis with Lactococcus garvieae: lack of in vitro synergy between ampicillin and gentamicin. JMM Case Reports 2 (1). \n                    https:\/\/doi.org\/10.1099\/jmmcr.0.000018","DOI":"10.1099\/jmmcr.0.000018"},{"issue":"4","key":"3367_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"J. S. Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr., Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clinical infectious diseases 30 (4):633\u2013638. \n                    https:\/\/doi.org\/10.1086\/313753","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"3367_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmi.2014.08.019","volume":"21","author":"O Oppegaard","year":"2015","unstructured":"Oppegaard O, Mylvaganam H, Kittang BR (2015) Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect 21(2):171\u2013178. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2014.08.019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3367_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10096-017-3172-8","volume":"37","author":"F Lindell","year":"2018","unstructured":"Lindell F, S\u00f6derquist B, Sundman K, Olaison L, K\u00e4llman J (2018) Prosthetic valve endocarditis caused by Propionibacterium species: a national registry-based study of 51 Swedish cases. Eur J Clin Microbiol Infect Dis 37(4):765\u2013771. \n                    https:\/\/doi.org\/10.1007\/s10096-017-3172-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3367_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1155\/2009\/538967","volume":"20","author":"MF Poulin","year":"2009","unstructured":"Poulin MF, Boivin G (2009) A case of disseminated infection caused by Streptococcus equi subspecies zooepidemicus. Can J Infect Dis Med Microbiol 20(2):59\u201361","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"3367_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s15010-015-0809-3","volume":"44","author":"G Lacave","year":"2016","unstructured":"Lacave G, Coutard A, Troche G, Augusto S, Pons S, Zuber B, Laurent V, Amara M, Couzon B, Bedos JP, Pangon B, Grimaldi D (2016) Endocarditis caused by Streptococcus canis: an emerging zoonosis? Infection 44(1):111\u2013114. \n                    https:\/\/doi.org\/10.1007\/s15010-015-0809-3","journal-title":"Infection"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3367-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:32:52Z","timestamp":1569972772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3367-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3367"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3367-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,8]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethical research committee (reference number 2013\/182) with the addition (2015\/81). Informed consent was obtained for the study of medical records.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and informed consent"}}]}}